» Articles » PMID: 36423464

Relation Between Macrophage Inflammatory Protein-1 and Intercellular Adhesion Molecule-1 and Computed Tomography Findings in Critically-ill Saudi Covid-19 Patients

Abstract

Background: Several, clinical and biochemical factors were suggested as risk factors for more severe forms of Covid-19. Macrophage inflammatory protein-1 alpha (MIP-1α, CCL3) is a chemokine mainly involved in cell adhesion and migration. Intracellular adhesion molecule 1 (ICAM-1) is an inducible cell adhesion molecule involved in multiple immune processes. The present study aimed to assess the relationship between baseline serum MIP-1α and ICAM-1 level in critically-ill Covid-19 patients and the severity of computed tomography (CT) findings.

Methods: The study included 100 consecutive critically-ill patients with Covid-19 infection. Diagnosis of infection was established on the basis of RT-PCR tests. Serum MIP-1α and ICAM-1 levels were assessed using commercially available ELISA kits. All patients were subjected to a high-resolution computed tomography assessment.

Results: According to the computed tomography severity score, patients were classified into those with moderate/severe (n=49) and mild (n = 51) pulmonary involvement. Severe involvement was associated with significantly higher MIP-1α and ICAM-1 level. Correlation analysis identified significant positive correlations between MIP-1α and age, D-dimer, IL6, in contrast, there was an inverse correlation with INF-alpha. Additionally, ICAM-1 showed significant positive correlations with age, D-Dimer,- TNF-α, IL6,while an inverse correlation with INF-alpha was observed.

Conclusions: MIP-1α and ICAM-1 level are related to CT radiological severity in Covid-19 patients. Moreover, these markers are well-correlated with other inflammatory markers suggesting that they can be used as reliable prognostic markers in Covid-19 patients.

Citing Articles

Causal relationship between circulating inflammatory cytokines and the risk of hernia: a bidirectional Mendelian randomization study.

Qi Y, Li C, Gao X, Zhang F J Int Med Res. 2025; 53(2):3000605251315923.

PMID: 39956620 PMC: 11831628. DOI: 10.1177/03000605251315923.


Utility of Protein Markers in COVID-19 Patients.

Alicia L, Maria Angeles O, Desiree M, Maximino R, Marilina G Int J Mol Sci. 2025; 26(2).

PMID: 39859366 PMC: 11766239. DOI: 10.3390/ijms26020653.


Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.

Condor Capcha J, Kamiar A, Robleto E, Saad A, Cui T, Wong A Proc Natl Acad Sci U S A. 2023; 120(48):e2308342120.

PMID: 37983492 PMC: 10691341. DOI: 10.1073/pnas.2308342120.

References
1.
Ma Q, Lei B, Chen R, Liu B, Lu W, Jiang H . Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro. Chin Med. 2022; 17(1):40. PMC: 8972667. DOI: 10.1186/s13020-022-00598-4. View

2.
Bermejo-Martin J, Gonzalez-Rivera M, Almansa R, Micheloud D, Tedim A, Dominguez-Gil M . Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020; 24(1):691. PMC: 7734467. DOI: 10.1186/s13054-020-03398-0. View

3.
Santos A, Couto C, Pereira S, Monteiro M . Is Serotonin the Missing Link between COVID-19 Course of Severity in Patients with Diabetes and Obesity?. Neuroendocrinology. 2022; 112(11):1039-1045. PMC: 9059061. DOI: 10.1159/000522115. View

4.
Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Udomsinprasert W . Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol. 2022; 32(4):e2323. DOI: 10.1002/rmv.2323. View

5.
Kaur S, Hussain S, Kolhe K, Kumar G, Tripathi D, Tomar A . Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep. 2021; 3(4):100303. PMC: 8106200. DOI: 10.1016/j.jhepr.2021.100303. View